Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Efficacy and safety of canagliflozin, an inhibitor of sodium-glucose cotransporter 2, when used in conjunction with insulin therapy in patients with type 2 diabetes
Nutritional solutions targeting side effects such as muscle loss and digestive discomfort are in high demand, especially as more consumers turn to GLP-1 medications
Our position: We are monitoring the July 23 PCAC meeting closely
The effects on blood sugar control also start to fade within the first couple of weeks, which is why people with diabetes need to have alternative management strategies in place before stopping
US$ 26.39
US$ 28.80
US$ 28.17
